https://de.marketscreener.com/kurs/aktie/THESEUS-PHARMACEUTICALS-I-127830003/news/Theseus-Pharmaceuticals-Inc-Nominiert-The-349-einen-EGFR-Inhibitor-der-vierten-Generation-als-En-41923213/?utm_source=telegram&utm_medium=social&utm_campaign=share